Clinical Trials Logo
  1. Home
  2. Phase 1
  3. NCT03740217

Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

Phase 1 Clinical Trial

Official title:
Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets and Evaluation of the Potential Impact of Concomitant Food Intake on the Relative Bioavailability of GKT137831 in Healthy Male Subjects

Clinical Trial Summary

The study will be a comparative oral bioavailability study between GKT137831 capsules and tablets, together with an assessment of the impact of concomitant food intake on the relative bioavailability of GKT137831 tablets. This will be a randomized three-way open cross-over study.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03740217
Study type Interventional
Source Calliditas Therapeutics AB
Contact
Status Completed
Phase Phase 1
Start date December 19, 2018
Completion date February 6, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT02010944 - A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels Phase 1
Completed NCT01415102 - A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Single Inhaled Doses Of PF-05212372. Phase 1
Completed NCT05068947 - Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Dose of GV101 in Healthy Subjects Phase 1
Completed NCT03273192 - A Study Of CinnoRA (Adalimumab-CinnaGen) And Adalimumab (Humira) In Healthy Subjects Phase 1
Completed NCT03883620 - Safety Study of Dengushield in Healthy Adults Phase 1
Completed NCT01091532 - A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleration And Time Course Of Blood Concentration Of UK-396,082 And Its Effects. Phase 1
Completed NCT02634489 - EC905 Pharmacokinetic Profile Study Phase 1
Completed NCT04327089 - Study to Evaluate the Pharmacokinetics and Drug-Drug Interactions of Setanaxib in Healthy Adult Male and Female Subjects Phase 1
Completed NCT03647670 - A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers Phase 1
Completed NCT03488719 - A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate Phase 1
Completed NCT03983876 - PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI) Phase 1
Completed NCT03273088 - Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects Phase 1
Recruiting NCT06214858 - The Safety, Tolerability, Pharmacokinetics and Food Effects of SHEN211 Tablet in Healthy Subjects Phase 1
Completed NCT04014257 - A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies Phase 1